This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXNPEG6T11W_L.jpg
Shares of the Chicago-based company rose more than 2% in premarket trading.
Due to the impairment charges, the company reported a second-quarter loss attributable to common shareholders of $1.65 billion, or $1.35 per share, compared with a profit of $449 million, or 37 cents a share a year earlier.
Excluding items, adjusted earnings were 80 cents per share, handily beating analysts’ average estimate of 65 cents, according to Refinitiv.
Sales rose 3.8% to $6.65 billion in the second quarter ended June 27, beating expectations for $6.54 billion.
